Furthermore, treatment of a mouse model of melanoma with the immunomodulator FTY720 inhibited tumor growth and angiogenesis by internalizing S1P receptor 1 (S1P1) and desensitizing it to S1P [109]. This evidence concerns the gene S1PR1 and neoplasm.